Patel Naimish
CRISPR Therapeutics AG-Common Shares · Chief Medical Officer
Patel Naimish is listed in filings as Chief Medical Officer at CRISPR Therapeutics AG-Common Shares. This profile follows SEC Form 4 activity through Jun 2, 2026, including sale activity and purchase activity. Recent filings connect the profile to CRISPR Therapeutics AG-Common Shares (CRSP). The current snapshot covers public activity from Oct 18, 2024 to Jun 2, 2026. Reported amounts are shown as $210.6K to $152.0K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $152k3.2k shares | SellMar 16, 2026 | $48.26 | $53.53 | |
| $141k3.9k shares | SellMay 29, 2025 | $35.94 | $53.53 | |
| $50k1.5k shares | BuyApr 3, 2025 | $32.96 | $53.53 |